(UroToday.com) In a GU session at the American Society for Radiation Oncology (ASTRO) Annual Congress, Dr. Padayachee presented on the role of tumor-targeted dose escalation for local control in localized prostate cancer. In this study, Dr. Padayachee and colleagues sought to assess rates of local control for patients with prostate cancer who received tumor-directed dose escalation, […]
(UroToday.com) In an educational session at the American Society for Radiation Oncology (ASTRO) Annual Congress focused on the best treatment for early prostate cancer, Dr. Stephenson presented on the potential role of focal therapy as an alternative for whole-gland therapy for intermediate-risk prostate cancer.
(UroToday.com) In an educational session at the American Society for Radiation Oncology (ASTRO) Annual Congress focused on the best treatment for early prostate cancer, Dr. Tree presented on the role of hypofractionation in early prostate cancer.
(UroToday.com) The 2021 American Society for Radiation Oncology (ASTRO) Hybrid Annual Meeting included a presentation by Dr. Fan Yang providing 24-month patient-reported quality of life outcomes from the randomized phase II trial of conventional versus hypofractionated radiation for high risk prostate cancer patients (CHIRP).
(UroToday.com) The 2021 American Society for Radiation Oncology (ASTRO) Hybrid Annual Meeting included a presentation by Dr. Jason Efstathiou discussing results of the NRG Oncology/RTOG 0926 trial. This trial assessed selective bladder preserving treatment by radiation therapy concurrent with radiosensitizing chemotherapy following a thorough restaging TURBT.
(UroToday.com) The 2021 American Society for Radiation Oncology (ASTRO) Hybrid Annual Meeting included a presentation by Dr. Patrick Cheung discussing long-term results from a prospective clinical trial assessing elective nodal irradiation with a simultaneous hypofractionated integrated prostate boost for localized-high-risk prostate cancer.
(UroToday.com) The 2021 American Society for Radiation Oncology (ASTRO) Hybrid Annual Meeting included a presentation by Dr. Kilian Salerno discussing detection failure patterns using advanced imaging in patients with biochemical recurrence following low dose rate brachytherapy for prostate cancer.
(UroToday.com) In a special session of the American Society for Radiation Oncology (ASTRO) and Society of Nuclear Medicine and Molecular Imaging (SNMMI) held at the 2021 ASTRO Annual Congress, Dr. Baruch presented on the role of molecular imaging using Fluciclovine PET imaging.
(UroToday.com) In the Clinical Trials and Innovation session of the American Society for Radiation Oncology (ASTRO) Annual Congress, Dr. Kishan presented results of an analysis assessing the impact of androgen deprivation therapy (ADT) use and duration with definitive radiotherapy in the treatment of patients with localized prostate cancer based on an individual patient data meta-analysis […]
(UroToday.com) In the Latin America ASTRO session of the American Society for Radiation Oncology (ASTRO) Annual Congress, Dr. Berlin presented on controversies in the management of patients with Muscle-invasive bladder cancer (MIBC). He began by highlighting that this is an exciting topic, over the last 10 to 15 years. Previously, he highlighted a self-perpetuating issue […]
